BWFG

First, ignore the headline valuation optics. The XBRL 'revenue' line of $2.83M (and the resulting P/S of 165x and 1,245% net margin) is a tiny fee item, not a bank's top line. Bankwell's real income statement, per the MD&A, runs on $198.3M of interest income and $98.9M of net interest income plus $9.4M of noninterest income. On the metrics that matter for a bank, BWFG is unremarkable-but-solid: FY2025 diluted EPS $4.45, ROAA 1.09%, ROAE 12.32%, and book value per share of $39.19 (tangible $38.85). Against a $58.60 price that is ~13.2x earnings and ~1.5x tangible book — roughly fair value for a small-cap commercial bank earning a low-teens ROE.

The reported +260% net-income and EPS growth is a normalization illusion, not durable acceleration. The MD&A's five-year table makes it plain: net income was $37.4M (2022), $36.7M (2023), then collapsed to $9.77M in 2024 on a $22.6M provision for credit losses, then recovered to $35.2M in 2025 as the provision fell back to $1.04M. Diluted EPS was actually higher in 2022 ($4.79) and 2023 ($4.67) than in 2025 ($4.45). So this is a bank that earns roughly $4.5–$4.8 in a normal year, not one compounding earnings — the 2024 dip was the anomaly. The genuine positive is net interest income rebounding from $83.3M to $98.9M as interest expense fell from $108.7M to $99.4M (deposit-cost relief and NIM expansion), and equity compounding +11.4% with a conservative 18% dividend payout that retains capital.